<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-24659" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Malakoplakia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kwan</surname>
            <given-names>Eddie</given-names>
          </name>
          <aff>Uniformed Services University of the Health Sciences</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Riley</surname>
            <given-names>Christopher A.</given-names>
          </name>
          <aff>San Antonio Uniformed Services Health Education Consortium</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Robinson</surname>
            <given-names>Carolyn A.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Eddie Kwan declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Christopher Riley declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Carolyn Robinson declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>31</day>
          <month>10</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-24659.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Malakoplakia is a rare inflammatory condition that typically occurs in immunocompromised individuals and is thought to be secondary to a bactericidal defect in macrophages. Malakoplakia typically affects the urinary tract, but the involvement of nearly every organ system has been reported. This activity reviews the evaluation and treatment of cutaneous malakoplakia and highlights the role of the interprofessional team in the care of patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of malakoplakia.</p></list-item><list-item><p>Assess&#x000a0;the appropriate evaluation of malakoplakia.</p></list-item><list-item><p>Differentiate&#x000a0;the management options available for malakoplakia.</p></list-item><list-item><p>Communicate&#x000a0;interprofessional team strategies for enhancing care coordination to improve the recognition of malakoplakia.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24659&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24659">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-24659.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Malakoplakia is a rare inflammatory condition that typically occurs in immunocompromised individuals. It was first described by Michaelis and Gutmann in 1902 after identifying the Michaelis-Gutmann bodies that are pathognomonic for this condition.<xref ref-type="bibr" rid="article-24659.r1">[1]</xref>&#x000a0;In 1903, von Hansemann coined the term &#x0201c;malakoplakia,&#x0201d; meaning &#x0201c;soft plaque.&#x0201d;<xref ref-type="bibr" rid="article-24659.r2">[2]</xref> This condition typically affects the urinary tract, but the involvement of nearly every organ system has been reported to include the pulmonary, gastrointestinal, endocrine, musculoskeletal, lymphatic, integumentary, and central nervous systems.<xref ref-type="bibr" rid="article-24659.r3">[3]</xref><xref ref-type="bibr" rid="article-24659.r4">[4]</xref>&#x000a0;While the exact etiology is unknown, <italic toggle="yes">Escherichia coli</italic> is the most common organism associated with this condition, although several others have been implicated.<xref ref-type="bibr" rid="article-24659.r3">[3]</xref><xref ref-type="bibr" rid="article-24659.r4">[4]</xref><xref ref-type="bibr" rid="article-24659.r5">[5]</xref>&#x000a0;Common treatment approaches include a combination of surgical excision and oral antibiotics or oral antibiotics as monotherapy.<xref ref-type="bibr" rid="article-24659.r1">[1]</xref><xref ref-type="bibr" rid="article-24659.r3">[3]</xref><xref ref-type="bibr" rid="article-24659.r6">[6]</xref><xref ref-type="bibr" rid="article-24659.r7">[7]</xref></p>
      </sec>
      <sec id="article-24659.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The exact pathogenesis of malakoplakia is poorly understood. It is thought to be due to an acquired bactericidal defect in macrophages. Beta-glucuronidase and cyclic guanosine monophosphate (cGMP) are required for normal microtubular function and phagolysosomal activity. Diminished beta-glucuronidase release and decreased cGMP levels have been demonstrated in patients with malakoplakia. This is believed to lead to decreased clearance of pathogenic organisms due to the persistence of phagolysosomes. The pathognomonic Michaelis-Gutman bodies (calcified intracytoplasmic inclusions) are thought to represent the phagolysosomes that have not been exocytosed.<xref ref-type="bibr" rid="article-24659.r3">[3]</xref><xref ref-type="bibr" rid="article-24659.r8">[8]</xref>&#x000a0;The disease process is typically associated with acquired immunosuppression. It has been described in patients with human immunodeficiency virus (HIV), organ transplants, malignancy, diabetes mellitus, connective tissue diseases, hepatitis C, and sarcoidosis.<xref ref-type="bibr" rid="article-24659.r4">[4]</xref><xref ref-type="bibr" rid="article-24659.r5">[5]</xref><xref ref-type="bibr" rid="article-24659.r9">[9]</xref>&#x000a0;While the disease process is rare in children, there have been cases associated with X-linked agammaglobulinemia, common variable immunodeficiency, and severe combined immunodeficiency.<xref ref-type="bibr" rid="article-24659.r5">[5]</xref><xref ref-type="bibr" rid="article-24659.r10">[10]</xref>&#x000a0;Malakoplakia is typically caused by gram-negative rods. The most common causative species of bacteria is <italic toggle="yes">Escherichia coli. Still, many</italic>&#x000a0;other bacterial organisms have been implicated, including <italic toggle="yes">Klebsiella</italic>, <italic toggle="yes">Proteus</italic>, <italic toggle="yes">Corynebacterium</italic>, <italic toggle="yes">Pseudomonas</italic>, <italic toggle="yes">Acinetobacter</italic>, <italic toggle="yes">Staphylococcus</italic>, <italic toggle="yes">Streptococcus</italic>, <italic toggle="yes">Enterococcus</italic>, <italic toggle="yes">Aerobacter</italic>, <italic toggle="yes">Rhodococcus</italic>, <italic toggle="yes">Mycobacterium</italic>, <italic toggle="yes">Salmonella</italic>, and <italic toggle="yes">Burkholderia</italic> species.<xref ref-type="bibr" rid="article-24659.r3">[3]</xref><xref ref-type="bibr" rid="article-24659.r4">[4]</xref><xref ref-type="bibr" rid="article-24659.r9">[9]</xref><xref ref-type="bibr" rid="article-24659.r11">[11]</xref></p>
      </sec>
      <sec id="article-24659.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Malakoplakia of the genitourinary tract is more prevalent in females, with an approximate ratio of 4&#x000a0;to 1. However, this ratio is lost in cases of malakoplakia found outside the genitourinary tract.&#x000a0; There is an increased risk of cutaneous malakoplakia in males, with an approximate ratio of 2&#x000a0;to 1. Malakoplakia is most common in older patients, with a peak incidence in those over 50 years of age but with a reported range of 6 weeks to 85 years of age.<xref ref-type="bibr" rid="article-24659.r3">[3]</xref><xref ref-type="bibr" rid="article-24659.r12">[12]</xref><xref ref-type="bibr" rid="article-24659.r13">[13]</xref><xref ref-type="bibr" rid="article-24659.r14">[14]</xref></p>
      </sec>
      <sec id="article-24659.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The exact pathogenesis of malakoplakia is not well defined. It has been demonstrated that the bactericidal capacity of macrophages is defective in malakoplakia. It is thought to be due to deficiencies in beta-glucuronidase and intracellular cGMP, which results in inadequate microtubular function and phagolysosomal activity and accumulates partially digested bacteria in macrophages.<xref ref-type="bibr" rid="article-24659.r3">[3]</xref><xref ref-type="bibr" rid="article-24659.r4">[4]</xref><xref ref-type="bibr" rid="article-24659.r6">[6]</xref><xref ref-type="bibr" rid="article-24659.r15">[15]</xref></p>
      </sec>
      <sec id="article-24659.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>On histology, the examination of affected tissue reveals dermal sheets of von Hansemann cells and a variable mixed inflammatory infiltrate consisting of neutrophils, lymphocytes, and plasma cells. Von Hansemann cells are enlarged foamy histiocytes with an eccentric, hyperchromatic nucleus and eosinophilic granules. Michaelis-Gutmann bodies are intracytoplasmic laminated concretions representing accumulations of calcified, iron-containing phagolysosomes considered partially degraded bacterial organisms. Michaelis-Gutmann bodies are pathognomonic for this condition. They can stain positive with periodic acid-Schiff, Perls, and von Kossa stains.<xref ref-type="bibr" rid="article-24659.r1">[1]</xref><xref ref-type="bibr" rid="article-24659.r2">[2]</xref><xref ref-type="bibr" rid="article-24659.r3">[3]</xref><xref ref-type="bibr" rid="article-24659.r5">[5]</xref><xref ref-type="bibr" rid="article-24659.r9">[9]</xref></p>
      </sec>
      <sec id="article-24659.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients often report a history of immunosuppression, which may be iatrogenic or medical. The clinical presentation of cutaneous malakoplakia is variable, with lesions that can appear as tender ulcerations, nodules, papules, and plaques or as fungating masses with perianal and genital skin being commonly involved. However, other organ systems can be involved, such as thorax, abdominal wall, head, neck, and extremities masses. It is important to keep malakoplakia on the differential diagnosis in individuals with a history of immunosuppression and recurrent infections.<xref ref-type="bibr" rid="article-24659.r1">[1]</xref><xref ref-type="bibr" rid="article-24659.r4">[4]</xref><xref ref-type="bibr" rid="article-24659.r6">[6]</xref><xref ref-type="bibr" rid="article-24659.r9">[9]</xref></p>
      </sec>
      <sec id="article-24659.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The evaluation of cutaneous malakoplakia is guided by the patient's history and physical examination. A skin biopsy of a suspicious lesion is essential to diagnose cutaneous malakoplakia and exclude other neoplastic, inflammatory, or infectious processes. Michaelis-Gutmann bodies and von Hansemann cells characterize histologic findings for cutaneous malakoplakia. Cultures of the lesions may help further guide antibiotic treatment.<xref ref-type="bibr" rid="article-24659.r4">[4]</xref><xref ref-type="bibr" rid="article-24659.r6">[6]</xref></p>
      </sec>
      <sec id="article-24659.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Given that malakoplakia is rare, large prospective trials are lacking, and evidence reporting successful treatment is largely anecdotal, there are no standardized treatment guidelines. General treatment principles include systemic antibiotics, surgical excision, and limiting immunosuppression.&#x000a0;Antibiotics that optimize the intracellular killing of bacteria by phagocytes have been successful in the treatment of malakoplakia. Such antibiotics include fluoroquinolones, trimethoprim/sulfamethoxazole, and rifampin.<xref ref-type="bibr" rid="article-24659.r3">[3]</xref><xref ref-type="bibr" rid="article-24659.r12">[12]</xref><xref ref-type="bibr" rid="article-24659.r14">[14]</xref><xref ref-type="bibr" rid="article-24659.r16">[16]</xref>&#x000a0;The optimal treatment duration of antibiotic therapy is unknown, but successful treatment may require long-term antibiotic therapy.<xref ref-type="bibr" rid="article-24659.r17">[17]</xref>&#x000a0;Theoretically, adding bethanechol, an anticholinergic agent, and ascorbic acid may increase cellular levels of cGMP within phagocytes and lead to the improved intracellular killing of bacteria.<xref ref-type="bibr" rid="article-24659.r3">[3]</xref><xref ref-type="bibr" rid="article-24659.r12">[12]</xref><xref ref-type="bibr" rid="article-24659.r16">[16]</xref>&#x000a0;Surgical excision of malakoplakia lesions should be considered based on the site affected, complications, or if medical treatment fails. Malakoplakia of the upper urinary tract tends to be aggressive. If the renal parenchyma is affected, nephrectomy should be considered. Additionally, if there is urethral, bladder, or ureteral obstruction, surgical excision or resection should be considered.<xref ref-type="bibr" rid="article-24659.r12">[12]</xref><xref ref-type="bibr" rid="article-24659.r17">[17]</xref><xref ref-type="bibr" rid="article-24659.r18">[18]</xref>&#x000a0;Combining surgical therapy and quinolone antibiotic therapy may be the most effective treatment.<xref ref-type="bibr" rid="article-24659.r16">[16]</xref></p>
        <p>Malakoplakia is often associated with acquired immunosuppression, including regimens used for organ transplantation or connective tissue diseases. One case series suggested that the use of prednisone and azathioprine was associated with decreased bacterial killing by neutrophils and monocytes; malakoplakia improved with discontinuation of immunosuppression.<xref ref-type="bibr" rid="article-24659.r19">[19]</xref>&#x000a0;There have been other reports of successful treatment of malakoplakia after either discontinuing or reducing the dose of prednisone and azathioprine.<xref ref-type="bibr" rid="article-24659.r16">[16]</xref>&#x000a0;Per a review of 140 cases of malakoplakia comparing treatment modalities, van der Voort et al suggested the following treatment steps: &#x0201c;(1) If feasible, stop prednisone and azathioprine treatment in those cases where malakoplakia developed during the use of this medication. (2) Perform surgical resection and drainage in combination with ciprofloxacin administration. (3) give ciprofloxacin hydrochloride, 500 mg twice daily if surgery is impossible. (4) Whether adding bethanechol and ascorbic acid offers any advantage to the other treatment modalities remains to be proved.&#x0201d;<xref ref-type="bibr" rid="article-24659.r16">[16]</xref></p>
      </sec>
      <sec id="article-24659.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis includes other infectious diseases, neoplastic, and reactive processes, including:</p>
        <list list-type="bullet">
          <list-item>
            <p>Tuberculosis</p>
          </list-item>
          <list-item>
            <p>Lepromatous leprosy</p>
          </list-item>
          <list-item>
            <p>Cryptococcus</p>
          </list-item>
          <list-item>
            <p>Actinomycosis</p>
          </list-item>
          <list-item>
            <p>Botryomycosis</p>
          </list-item>
          <list-item>
            <p>Leishmaniasis</p>
          </list-item>
          <list-item>
            <p>Condyloma lata</p>
          </list-item>
          <list-item>
            <p>Cutaneous Crohn disease</p>
          </list-item>
          <list-item>
            <p>Sarcoidosis</p>
          </list-item>
          <list-item>
            <p>Foreign body granuloma</p>
          </list-item>
          <list-item>
            <p>Hidradenitis suppurativa</p>
          </list-item>
          <list-item>
            <p>Granular cell tumors</p>
          </list-item>
          <list-item>
            <p>Xanthomas</p>
          </list-item>
          <list-item>
            <p>Lymphoma<xref ref-type="bibr" rid="article-24659.r1">[1]</xref><xref ref-type="bibr" rid="article-24659.r3">[3]</xref><xref ref-type="bibr" rid="article-24659.r20">[20]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24659.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Cutaneous malakoplakia typically presents as a self-limited condition that rarely leads to death. Lesions can undergo spontaneous regression in immunocompetent individuals with a mean 4 to 6 months duration. In individuals treated with surgery with or without antibiotics, there has been a reported 81% cure rate. However, the course of the disease can be variable and can relapse, cause local disfigurement, or present with internal organ involvement despite medical and surgical management.<xref ref-type="bibr" rid="article-24659.r3">[3]</xref><xref ref-type="bibr" rid="article-24659.r7">[7]</xref><xref ref-type="bibr" rid="article-24659.r12">[12]</xref><xref ref-type="bibr" rid="article-24659.r16">[16]</xref><xref ref-type="bibr" rid="article-24659.r21">[21]</xref><xref ref-type="bibr" rid="article-24659.r16">[16]</xref></p>
      </sec>
      <sec id="article-24659.s12" sec-type="Complications">
        <title>Complications</title>
        <p>The associated complications of malakoplakia are largely related to the location and severity of involvement. For example, malakoplakia of the urinary system may be a cause of acute kidney injury,&#x000a0;recurrent urinary tract infections, and renal failure and is very rarely fatal.<xref ref-type="bibr" rid="article-24659.r22">[22]</xref><xref ref-type="bibr" rid="article-24659.r23">[23]</xref><xref ref-type="bibr" rid="article-24659.r24">[24]</xref><xref ref-type="bibr" rid="article-24659.r25">[25]</xref><xref ref-type="bibr" rid="article-24659.r26">[26]</xref></p>
      </sec>
      <sec id="article-24659.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients with a history of immunosuppression, whether iatrogenic or secondary to another medical condition, should be warned about potential side effects or sequelae, such as malakoplakia. Patients should be instructed to inform their provider of any persistent, enlarging, or ulcerating skin lesions.</p>
      </sec>
      <sec id="article-24659.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Malakoplakia is a very rare inflammatory condition that typically occurs in immunocompromised individuals. Case reports from the literature have reported successful treatment with antibiotics, surgical excision, or a combination of both. Large randomized controlled studies do not exist for any specific treatments. Because malakoplakia can affect nearly every organ system, this condition is best handled with an&#x000a0;interprofessional team approach. Such a team may include the provider managing the immunosuppressive condition or regimen (such as an infectious disease specialist, rheumatologist, primary clinician, oncologist, or transplant clinician), dermatologist, surgeon, and pharmacist. The initial provider may coordinate with the pharmacist for the ideal immunosuppressive regimen. When malakoplakia is suspected, a dermatologist or surgeon may be consulted to perform a biopsy. Depending on the location and complexity of the lesion(s), an infectious disease specialist, dermatologist, and surgeon may be needed to maximize the management of the malakoplakia. Identifying and treating patients who are at risk early and keeping malakoplakia on the differential may reduce morbidity.</p>
      </sec>
      <sec id="article-24659.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24659&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24659">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/malakoplakia/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=24659">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/24659/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=24659">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-24659.s16">
        <title>References</title>
        <ref id="article-24659.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Afonso</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Ando</surname>
                <given-names>PN</given-names>
              </name>
              <name>
                <surname>Padilha</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Michalany</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Porro</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Cutaneous malakoplakia: case report and review.</article-title>
            <source>An Bras Dermatol</source>
            <year>2013</year>
            <season>May-Jun</season>
            <volume>88</volume>
            <issue>3</issue>
            <fpage>432</fpage>
            <page-range>432-7</page-range>
            <pub-id pub-id-type="pmid">23793204</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24659.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lowitt</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Kariniemi</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Niemi</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Kao</surname>
                <given-names>GF</given-names>
              </name>
            </person-group>
            <article-title>Cutaneous malacoplakia: a report of two cases and review of the literature.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1996</year>
            <month>Feb</month>
            <volume>34</volume>
            <issue>2 Pt 2</issue>
            <fpage>325</fpage>
            <page-range>325-32</page-range>
            <pub-id pub-id-type="pmid">8655720</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24659.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kyriakou</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gialeli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Vryzaki</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Koumoundourou</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Glentis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Georgiou</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Malacoplakia of the skin: overview of a rare clinical entity.</article-title>
            <source>Dermatol Online J</source>
            <year>2019</year>
            <month>Jun</month>
            <day>15</day>
            <volume>25</volume>
            <issue>6</issue>
            <pub-id pub-id-type="pmid">31329385</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24659.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Le&#x000e3;o</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Duarte</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Gamba</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ramos</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Rossi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Galv&#x000e3;o</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>David-Neto</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Nahas</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Shikanai-Yasuda</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Pierrotti</surname>
                <given-names>LC</given-names>
              </name>
            </person-group>
            <article-title>Malakoplakia after renal transplantation in the current era of immunosuppressive therapy: case report and literature review.</article-title>
            <source>Transpl Infect Dis</source>
            <year>2012</year>
            <month>Dec</month>
            <volume>14</volume>
            <issue>6</issue>
            <fpage>E137</fpage>
            <page-range>E137-41</page-range>
            <pub-id pub-id-type="pmid">23025504</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24659.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Medlicott</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Magi-Galluzzi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jimenez</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Trpkov</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Malakoplakia associated with prostatic adenocarcinoma: Report of 4 cases and literature review.</article-title>
            <source>Ann Diagn Pathol</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>22</volume>
            <fpage>33</fpage>
            <page-range>33-7</page-range>
            <pub-id pub-id-type="pmid">27180057</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24659.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Coates</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Del Pero</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Nassif</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>A Case of Cutaneous Malakoplakia in the Head and Neck Region and Review of the Literature.</article-title>
            <source>Head Neck Pathol</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>10</volume>
            <issue>4</issue>
            <fpage>444</fpage>
            <page-range>444-450</page-range>
            <pub-id pub-id-type="pmid">27154024</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24659.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elkeeb</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hopkins</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Wada</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rhoads</surname>
                <given-names>JLW</given-names>
              </name>
            </person-group>
            <article-title>A case of primary cutaneous malakoplakia in a cardiac transplant recipient.</article-title>
            <source>JAAD Case Rep</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>4</volume>
            <issue>10</issue>
            <fpage>982</fpage>
            <page-range>982-984</page-range>
            <pub-id pub-id-type="pmid">30406173</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24659.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Crevel</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Curfs</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>van der Ven</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Assmann</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Meis</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>van der Meer</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Functional and morphological monocyte abnormalities in a patient with malakoplakia.</article-title>
            <source>Am J Med</source>
            <year>1998</year>
            <month>Jul</month>
            <volume>105</volume>
            <issue>1</issue>
            <fpage>74</fpage>
            <page-range>74-7</page-range>
            <pub-id pub-id-type="pmid">9688025</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24659.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kohl</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Hans</surname>
                <given-names>CP</given-names>
              </name>
            </person-group>
            <article-title>Cutaneous malakoplakia.</article-title>
            <source>Arch Pathol Lab Med</source>
            <year>2008</year>
            <month>Jan</month>
            <volume>132</volume>
            <issue>1</issue>
            <fpage>113</fpage>
            <page-range>113-7</page-range>
            <pub-id pub-id-type="pmid">18181662</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24659.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Archer</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Abramowsky</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Kobrynski</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Simoneaux</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vogler</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Ricketts</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Parker</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Elawahbdeh</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Shehata</surname>
                <given-names>BM</given-names>
              </name>
            </person-group>
            <article-title>Malakoplakia and primary immunodeficiency.</article-title>
            <source>J Pediatr</source>
            <year>2014</year>
            <month>Nov</month>
            <volume>165</volume>
            <issue>5</issue>
            <fpage>1053</fpage>
            <page-range>1053-6</page-range>
            <pub-id pub-id-type="pmid">25155967</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24659.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tulpule</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Bharatia</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Pradhan</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Tawade</surname>
                <given-names>YV</given-names>
              </name>
            </person-group>
            <article-title>Cutaneous malakoplakia: Interesting case report and review of literature.</article-title>
            <source>Indian J Dermatol Venereol Leprol</source>
            <year>2017</year>
            <season>Sep-Oct</season>
            <volume>83</volume>
            <issue>5</issue>
            <fpage>584</fpage>
            <page-range>584-586</page-range>
            <pub-id pub-id-type="pmid">28749381</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24659.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stanton</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Maxted</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Malacoplakia: a study of the literature and current concepts of pathogenesis, diagnosis and treatment.</article-title>
            <source>J Urol</source>
            <year>1981</year>
            <month>Feb</month>
            <volume>125</volume>
            <issue>2</issue>
            <fpage>139</fpage>
            <page-range>139-46</page-range>
            <pub-id pub-id-type="pmid">7009885</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24659.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yousef</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Naghibi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hamodat</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Malakoplakia outside the urinary tract.</article-title>
            <source>Arch Pathol Lab Med</source>
            <year>2007</year>
            <month>Feb</month>
            <volume>131</volume>
            <issue>2</issue>
            <fpage>297</fpage>
            <page-range>297-300</page-range>
            <pub-id pub-id-type="pmid">17284117</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24659.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dasgupta</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Womack</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Turner</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Blackford</surname>
                <given-names>HN</given-names>
              </name>
            </person-group>
            <article-title>Malacoplakia: von Hansemann's disease.</article-title>
            <source>BJU Int</source>
            <year>1999</year>
            <month>Sep</month>
            <volume>84</volume>
            <issue>4</issue>
            <fpage>464</fpage>
            <page-range>464-9</page-range>
            <pub-id pub-id-type="pmid">10468763</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24659.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abdou</surname>
                <given-names>NI</given-names>
              </name>
              <name>
                <surname>NaPombejara</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sagawa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ragland</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Stechschulte</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Nilsson</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Gourley</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Watanabe</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Lindsey</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Allen</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Malakoplakia: evidence for monocyte lysosomal abnormality correctable by cholinergic agonist in vitro and in vivo.</article-title>
            <source>N Engl J Med</source>
            <year>1977</year>
            <month>Dec</month>
            <day>29</day>
            <volume>297</volume>
            <issue>26</issue>
            <fpage>1413</fpage>
            <page-range>1413-9</page-range>
            <pub-id pub-id-type="pmid">200843</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24659.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van der Voort</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>ten Velden</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Wassenaar</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Silberbusch</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Malacoplakia. Two case reports and a comparison of treatment modalities based on a literature review.</article-title>
            <source>Arch Intern Med</source>
            <year>1996</year>
            <month>Mar</month>
            <day>11</day>
            <volume>156</volume>
            <issue>5</issue>
            <fpage>577</fpage>
            <page-range>577-83</page-range>
            <pub-id pub-id-type="pmid">8604965</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24659.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ci&#x00119;szczyk</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Puderecki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wronecki</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Burdan</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Szumi&#x00142;o</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Malakoplakia of the urinary system.</article-title>
            <source>Folia Med Cracov</source>
            <year>2019</year>
            <volume>59</volume>
            <issue>2</issue>
            <fpage>67</fpage>
            <page-range>67-74</page-range>
            <pub-id pub-id-type="pmid">31659350</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24659.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Long</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Althausen</surname>
                <given-names>AF</given-names>
              </name>
            </person-group>
            <article-title>Malacoplakia: a 25-year experience with a review of the literature.</article-title>
            <source>J Urol</source>
            <year>1989</year>
            <month>Jun</month>
            <volume>141</volume>
            <issue>6</issue>
            <fpage>1328</fpage>
            <page-range>1328-31</page-range>
            <pub-id pub-id-type="pmid">2657104</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24659.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Biggar</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Crawford</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cardella</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bear</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Gladman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Reynolds</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>Malakoplakia and immunosuppressive therapy. Reversal of clinical and leukocyte abnormalities after withdrawal of prednisone and azathioprine.</article-title>
            <source>Am J Pathol</source>
            <year>1985</year>
            <month>Apr</month>
            <volume>119</volume>
            <issue>1</issue>
            <fpage>5</fpage>
            <page-range>5-11</page-range>
            <pub-id pub-id-type="pmid">3885752</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24659.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sarkell</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Dannenberg</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Blaylock</surname>
                <given-names>WK</given-names>
              </name>
              <name>
                <surname>Patterson</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Cutaneous malacoplakia.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1994</year>
            <month>May</month>
            <volume>30</volume>
            <issue>5 Pt 2</issue>
            <fpage>834</fpage>
            <page-range>834-6</page-range>
            <pub-id pub-id-type="pmid">7513327</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24659.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shawaf</surname>
                <given-names>AZ</given-names>
              </name>
              <name>
                <surname>Boushi</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Douri</surname>
                <given-names>TH</given-names>
              </name>
            </person-group>
            <article-title>Perianal cutaneous malakoplakia in an immunocompetent patient.</article-title>
            <source>Dermatol Online J</source>
            <year>2010</year>
            <month>Jan</month>
            <day>15</day>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>10</fpage>
            <pub-id pub-id-type="pmid">20137752</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24659.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chemouny</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Sannier</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hanouna</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Champion</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Vrtovsnik</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Daugas</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Malakoplakia as a cause of severe hypercalcemia through ectopic 25-hydroxyvitamin D3 1-alpha-hydroxylase expression: A case report.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>97</volume>
            <issue>40</issue>
            <fpage>e12090</fpage>
            <pub-id pub-id-type="pmid">30290590</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24659.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Amsellem</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Corgibet</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ponnelle</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Dauendorffer</surname>
                <given-names>JN</given-names>
              </name>
            </person-group>
            <article-title>[Penile malakoplakia associated with lichen sclerosus].</article-title>
            <source>Ann Dermatol Venereol</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>146</volume>
            <issue>12</issue>
            <fpage>812</fpage>
            <page-range>812-816</page-range>
            <pub-id pub-id-type="pmid">31627929</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24659.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Daroux</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Frimat</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mirault</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Fleury</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lemaitre</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Noel</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Vanhille</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>[Renal malakoplakia: an underestimate cause of renal failure].</article-title>
            <source>Nephrol Ther</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>7</volume>
            <issue>2</issue>
            <fpage>111</fpage>
            <page-range>111-6</page-range>
            <pub-id pub-id-type="pmid">21126934</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24659.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>SCOTT</surname>
                <given-names>EV</given-names>
              </name>
              <name>
                <surname>SCOTT</surname>
                <given-names>WF</given-names>
              </name>
            </person-group>
            <article-title>A fatal case of malakoplakia of the urinary tract.</article-title>
            <source>J Urol</source>
            <year>1958</year>
            <month>Jan</month>
            <volume>79</volume>
            <issue>1</issue>
            <fpage>52</fpage>
            <page-range>52-6</page-range>
            <pub-id pub-id-type="pmid">13502912</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24659.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lambird</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Yardley</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Urinary tract malakoplakia: report of a fatal case with ultrastructural observations of Michaelis-Gutman bodies.</article-title>
            <source>Johns Hopkins Med J</source>
            <year>1970</year>
            <month>Jan</month>
            <volume>126</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-14</page-range>
            <pub-id pub-id-type="pmid">4190047</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
